Dr. Olugbeminiyi Fadeyi


Originally from Nigeria, Niyi completed his B.Sc in Chemistry at Obafemi Awolowo University, Nigeria under the direction of Professor Craig Obafemi. Following his undergraduate studies, he worked for GlaxoSmithKline, Nigeria as a scientist and later moved to the US for graduate studies. He obtained his Masters in 2007 from Tennessee State University, under the direction of Prof.  Cosmas Okoro.

He continued on to the doctoral program at Vanderbilt University, where under the mentorship of Prof. Craig Lindsley, his research focused on developing new synthetic methodologies and application to towards natural products synthesis. In 2011, Niyi obtained his doctorate degree and joined Prof. Matthew Shair’s laboratories at the department of chemistry and chemical biology, Harvard University as a UNCF/Merck postdoctoral fellow. He joined Pfizer Inc., Groton in 2014, where he was a Principal Scientist with the Inflammation & Immunology-Rare Diseases division in World Wide Medicinal Chemistry. After 3 years at Pfizer, he joined Merck Exploratory Science Center as a Molecular Invention Scientist where he will be developing a platform that integrates chemistry and biology to study novel mechanistic basis of human diseases to develop new therapeutics.